Catalyst Wire Dossier Catalyst Wire Dossier

Buscopan (hyoscine butylbromide)

hyoscine butylbromide · Boehringer Ingelheim
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Buscopan (hyoscine butylbromide), covering 2017-02-13 to 2017-02-13. Get the full timeline:

Most recent: Clinical Trial Update: Determine the Bioequivalence of Two Formulations of Hyoscine Butylbromide. [Phase 1]

See pricing